Skip to content

Product Performance of a Toric Contact Lens

A Study to Evaluate the Product Performance of a Prism-Ballasted Toric Contact Lens When Worn by Currently Adapted Soft Contact Lens Wearers.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00658996
Enrollment
220
Registered
2008-04-16
Start date
2008-04-30
Completion date
2008-06-30
Last updated
2011-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia

Brief summary

Product performance of a Bausch & Lomb Toric Contact Lens compared to Ciba Vision Focus Daily Toric Contact Lens

Interventions

DEVICESofLens DD Toric

daily disposable wear contact lens for 2 weeks

DEVICECiba Vision Focus Dailies Toric Contact Lens

daily disposable wear contact lens for 2 weeks

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is an adapted soft contact lens wearer with astigmatism of 0.50 Diopter or greater * Visual acuity (VA) correctable to 0.3 logMar or better (driving vision) * Clear central cornea

Exclusion criteria

* Systemic disease affecting ocular health * Using systemic or topical medications * Wears monovision or multifocal contact lenses * Any grade 2 or greater slit lamp findings * Adapted wearer of Ciba Focus Dailies Toric lens upon study entry

Design outcomes

Primary

MeasureTime frameDescription
Symptoms and ComplaintsOver-all follow-up visits for 2 week period1-100 Scale for each eye. Zero represented the least favorable rating and 100 represented the most favorable.
Contact Lens High Contrast Visual AcuityOver-all follow-up visits, 2 weeksVA measures at each scheduled visit were averaged to obtain an overall measure for each eye. A non-inferiority upper bound of 0.06 (3 letters) were used to assess the difference (Test - Control) in overall logMAR VA.

Secondary

MeasureTime frameDescription
Slit Lamp FindingsOver-all follow-up visits, 2 weeksGraded 0-4 where 0=none and 4=severe on measure of epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates

Countries

Malaysia

Participant flow

Recruitment details

This 4-week study was conducted at 12 sites in Asia. First participant enrolled 4/16/08, last participant visit was 6/20/08

Pre-assignment details

220 participants were enrolled in the study, 4 participants were ineligible at screening visit, 216 Subjects started the first intervention. 211 participants started the second intervention. 209 participants completed the study.

Participants by arm

ArmCount
Entire Study Population
Population enrolled at start of study
216
Total216

Withdrawals & dropouts

PeriodReasonFG000FG001
Crossover PeriodIneligible11
Crossover PeriodPhysician Decision10
First InterventionLack of lenses01
First InterventionPositive slit lamp finding10
Second InterventionDeveloped a stye on upper lid10
Second InterventionPositive slit lamp finding01

Baseline characteristics

CharacteristicEntire Study Population
Age Continuous28.7 Years
STANDARD_DEVIATION 7.19
Race/Ethnicity, Customized
Asian
216 participants
Race/Ethnicity, Customized
Black
0 participants
Race/Ethnicity, Customized
Other
0 participants
Race/Ethnicity, Customized
White
0 participants
Sex: Female, Male
Female
150 Participants
Sex: Female, Male
Male
66 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 2150 / 216
serious
Total, serious adverse events
0 / 2150 / 216

Outcome results

Primary

Contact Lens High Contrast Visual Acuity

VA measures at each scheduled visit were averaged to obtain an overall measure for each eye. A non-inferiority upper bound of 0.06 (3 letters) were used to assess the difference (Test - Control) in overall logMAR VA.

Time frame: Over-all follow-up visits, 2 weeks

Population: All eligible, dispensed eyes

ArmMeasureValue (MEAN)Dispersion
SofLens DD ToricContact Lens High Contrast Visual Acuity-0.007 LogMARStandard Deviation 0.0669
Focus Dailies ToricContact Lens High Contrast Visual Acuity-0.014 LogMARStandard Deviation 0.0696
Primary

Symptoms and Complaints

1-100 Scale for each eye. Zero represented the least favorable rating and 100 represented the most favorable.

Time frame: Over-all follow-up visits for 2 week period

Population: All eligible, dispensed eyes, Overall follow-up visits.

ArmMeasureGroupValue (MEAN)Dispersion
SofLens DD ToricSymptoms and ComplaintsIrritation83.0 Scores on a ScaleStandard Deviation 15.6
SofLens DD ToricSymptoms and ComplaintsComfort79.3 Scores on a ScaleStandard Deviation 17.1
SofLens DD ToricSymptoms and ComplaintsLens Cleanliness87.5 Scores on a ScaleStandard Deviation 12.7
SofLens DD ToricSymptoms and ComplaintsItching86.4 Scores on a ScaleStandard Deviation 14.9
SofLens DD ToricSymptoms and ComplaintsRedness86.3 Scores on a ScaleStandard Deviation 14.9
SofLens DD ToricSymptoms and ComplaintsDryness77.4 Scores on a ScaleStandard Deviation 18
SofLens DD ToricSymptoms and ComplaintsLens Awareness78.8 Scores on a ScaleStandard Deviation 17.9
SofLens DD ToricSymptoms and ComplaintsLens Handling87.4 Scores on a ScaleStandard Deviation 13
SofLens DD ToricSymptoms and ComplaintsVision77.1 Scores on a ScaleStandard Deviation 19.1
SofLens DD ToricSymptoms and ComplaintsOverall Impression78.7 Scores on a ScaleStandard Deviation 16.2
SofLens DD ToricSymptoms and ComplaintsEnd of Day Comfort73.5 Scores on a ScaleStandard Deviation 19.6
Focus Dailies ToricSymptoms and ComplaintsOverall Impression75.9 Scores on a ScaleStandard Deviation 17.5
Focus Dailies ToricSymptoms and ComplaintsEnd of Day Comfort71.5 Scores on a ScaleStandard Deviation 19.9
Focus Dailies ToricSymptoms and ComplaintsLens Awareness75.6 Scores on a ScaleStandard Deviation 20.4
Focus Dailies ToricSymptoms and ComplaintsLens Cleanliness86.5 Scores on a ScaleStandard Deviation 13
Focus Dailies ToricSymptoms and ComplaintsIrritation79.3 Scores on a ScaleStandard Deviation 19.6
Focus Dailies ToricSymptoms and ComplaintsRedness81.5 Scores on a ScaleStandard Deviation 19.5
Focus Dailies ToricSymptoms and ComplaintsVision84.3 Scores on a ScaleStandard Deviation 14.6
Focus Dailies ToricSymptoms and ComplaintsComfort77.7 Scores on a ScaleStandard Deviation 17.6
Focus Dailies ToricSymptoms and ComplaintsItching83.9 Scores on a ScaleStandard Deviation 17.2
Focus Dailies ToricSymptoms and ComplaintsDryness73.7 Scores on a ScaleStandard Deviation 20.3
Focus Dailies ToricSymptoms and ComplaintsLens Handling76.1 Scores on a ScaleStandard Deviation 21.2
Secondary

Slit Lamp Findings

Graded 0-4 where 0=none and 4=severe on measure of epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates

Time frame: Over-all follow-up visits, 2 weeks

Population: All dispensed eyes, over all follow-up visits

ArmMeasureGroupValue (NUMBER)
SofLens DD ToricSlit Lamp FindingsSlit Lamp Findings </= Grade 2430 Eyes
SofLens DD ToricSlit Lamp FindingsSlit Lamp Findings > Grade 20 Eyes
Focus Dailies ToricSlit Lamp FindingsSlit Lamp Findings > Grade 22 Eyes
Focus Dailies ToricSlit Lamp FindingsSlit Lamp Findings </= Grade 2428 Eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026